The takeaway here is to understand the risks and the motivations of companies selling the drugs that address diseases. “The pharmaceutical industry has made a business out of targeting them with specific drugs and antibodies. I can’t stand it any longer,” said Dr. Dinarello, who helped us understand fever and interleukins. “Psoriasis, arthritis, bowel disease. The industry is targeting different ways of treating them—all targeting cytokines.” But the risk is infection, even cancer. Why? Because, as you now know, you’re tinkering with a very sensitive system.
